LONDON, August 27 /PRNewswire/ --

Following the successful acquisition of Drug Development Solutions ('DDS') in February, Chiltern, a leading contract research organization, announced today that it has fully integrated its two early Phase units into a single operation branded as Chiltern Early Phase.

SAN DIEGO and INDIANAPOLIS, August 27 /PRNewswire/ --

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis. The companies were aware of the pancreatitis cases referenced in the alert, as well as others, and previously reported these cases to the FDA. The complete conference call replay will be available through Amylin's and Lilly's corporate websites after the call.

FRIMLEY, England, August 27 /PRNewswire/ --

- Guidance Secures Access to Ranibizumab for all Suitable Patients on the NHS

- NICE Confirms Final Details of Innovative Ranibizumab Reimbursement Scheme

- Novartis Prepares for Nationwide Roll-out of Scheme Across England and Wales

Novartis Pharmaceuticals UK Ltd (Novartis) today welcomed the Final National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Guidance for age-related macular degeneration.

WASHINGTON, August 26 /PRNewswire/ --

Crude oil prices "could" fall below US$100 per barrel over the next 18 months on slowing worldwide demand and an increase in oil production, Energy Information Administration (EIA) chief Guy Caruso said Tuesday.

Caruso made the comment to reporters at the Platts Energy Podium in Washington.

"I think [prices] could fall below US$100 a barrel on slowing global demand and rising production in the US, Brazil and Canada, and from OPEC states such as Saudi Arabia and Angola," Caruso said.

PEMBROKE, Bermuda, August 26 /PRNewswire/ --

Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced the appointment of Patrick de Saint-Aignan to its Board of Directors. Mr. de Saint-Aignan has over 30 years experience in investment banking.

Allied World President and Chief Executive Officer Scott Carmilani commented, "We welcome Patrick to our Board of Directors. He has tremendous experience in financial services and will bring a wealth of knowledge to both our Board and our company."

STOCKHOLM, Sweden, August 26 /PRNewswire/ --

Elekta recently announced that it has received CE Mark clearance to distribute Elekta Compact(TM), the latest addition to its line of treatment systems, offering clinicians an easy to implement, more affordable solution for radiation therapy. CE Mark clearance from the European Union certifies Elekta Compact has met health, safety and environmental requirements for consumer safety.

Elekta Compact was developed to address the demanding clinical requirements in emerging markets, which require a low energy system that can be dedicated to specialized cases. Its ultra-compact design also makes it more accessible to clinicians who want to provide their patients with optimal radiation therapy care.